Piezo Phire
The most affordable device in the Implosion Group line (700 EUR) — a piezo-based localized 'implosive charge' unit launched at the maker's own FractalU conference.
- The maker's own comparison table (published on the PhiRay page) describes Piezo Phire as accurate across '2–4 times the harmonics' of Theraphi, with 'many reports of solution to local pain, circulation, inflammation' — explicitly framed as localized rather than full-body effect.
- The same table states many former Theraphi users found Piezophire 'actually MORE powerful and effective than Theraphi' for localized issues, despite costing roughly 1/40th as much.
- The product ships with a dedicated 'quick start guide' and a detailed manual, and was publicly launched at the maker's FractalU conference alongside a recorded presentation on its history and science.
Named as the programmer behind Piezophire's software and a co-presenter at its FractalU launch — a real, findable collaborator with his own site and body of work.
Same proprietary frequency-selection framework cited across the maker's full product line.
EVERY SOURCE IS NAMED SO YOU CAN VERIFY IT YOURSELF. NAMING A SOURCE IS NOT ENDORSING IT.
- What does 'accurate across 2–4x the harmonics of Theraphi' actually mean as a measurable, testable claim — and has anyone outside the maker's circle tested it?
- What is the actual mechanism proposed for a piezo device affecting pain/inflammation/circulation, and does it have any grounding independent of the maker's own negentropy framework?
Piezo Phire is positioned as the entry-level, localized-effect device in the ecosystem — cheapest by a wide margin (700 EUR vs. $2,500–$6,900 for the full-body devices), and explicitly marketed as complementary to Plasmaphire and PhiRay rather than competing with them (bundled discounts are offered for ordering together).
It was launched via the maker's own FractalU conference, tying the product directly to the community/education side of the ecosystem rather than being sold as a standalone consumer device.
SOURCE: piezophire.com (scraped 2026-07-09, partial — page exceeded scrape size limit); cross-referenced against the seller's comparison table on geometricmodels.org/2025/02/09/phiray
For localized pain/inflammation use, how does it compare to established TENS/PEMF consumer devices on the market?
Not addressed by the source material — the Atlas has not yet compared Piezophire against conventional electrotherapy devices already in medical use.
Report from the field →PhiRay
A $6,900 plasma-and-magnetic-field device marketed as the direct replacement for the maker's earlier Theraphi system — claimed to be 2–4x more powerful at roughly a quarter of the cost.
Plasmaphire
A battery-powered, portable pair of plasma spheres (2,500 EUR) explicitly marketed by its own maker as 'experimental' and unable to make medical claims — designed for use away from mains power, including outdoors.
PhireCrystal
A $434 (with shipping) crystal marketed as a 'gravity diode' when piezoelectrically triggered by the maker's Piezophire device — framed explicitly against a claimed Atlantean 'Fire Crystal' lineage.